These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6852236)

  • 1. Role of the quinone structure in the mitochondrial damage induced by antitumor anthracyclines. Comparison of adriamycin and 5-iminodaunorubicin.
    Pollakis G; Goormaghtigh E; Ruysschaert JM
    FEBS Lett; 1983 May; 155(2):267-72. PubMed ID: 6852236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin and derivatives interaction with the mitochondrial membrane: O2 consumption and free radicals formation.
    Pollakis G; Goormaghtigh E; Delmelle M; Lion Y; Ruysschaert JM
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):445-59. PubMed ID: 6463367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives.
    Praet M; Ruysschaert JM
    Biochim Biophys Acta; 1993 Jun; 1149(1):79-85. PubMed ID: 8391322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damages of the mitochondrial membrane in Adriamycin treated mice.
    Praet M; Pollakis G; Goormaghtigh E; Ruysschaert JM
    Cancer Lett; 1984 Nov; 25(1):89-96. PubMed ID: 6097353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial membrane modifications induced by adriamycin-mediated electron transport.
    Goormaghtigh E; Pollakis G; Ruysschaert JM
    Biochem Pharmacol; 1983 Mar; 32(5):889-93. PubMed ID: 6838634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.
    Solem LE; Henry TR; Wallace KB
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):214-22. PubMed ID: 7527602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of DNA scission and cytotoxicity produced by Adriamycin and 5-iminodaunorubicin in human colon carcinoma cells.
    Johnston JB; Zwelling LA; Kerrigan D; Lloyd LS; Glazer RI
    Biochem Pharmacol; 1983 Jul; 32(14):2255-8. PubMed ID: 6870948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro modifications of the mitochondrial membrane induced by 4' Epi-adriamycin.
    Praet M; Laghmiche M; Pollakis G; Goormaghtigh E; Ruysschaert JM
    Biochem Pharmacol; 1986 Sep; 35(17):2923-8. PubMed ID: 3461789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
    Conklin KA
    Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.
    Davies KJ; Doroshow JH; Hochstein P
    FEBS Lett; 1983 Mar; 153(1):227-30. PubMed ID: 6298008
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
    Singh Y; Ulrich L; Katz D; Bowen P; Krishna G
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):9-23. PubMed ID: 2763305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
    Tong GL; Henry DW; Acton EM
    J Med Chem; 1979 Jan; 22(1):36-9. PubMed ID: 423181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of free radical scavengers reducing adriamycin mitochondrial toxicity.
    Praet M; Calderon PB; Pollakis G; Roberfroid M; Ruysschaert JM
    Biochem Pharmacol; 1988 Dec; 37(24):4617-22. PubMed ID: 2849451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G; Londos-Gagliardi D
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis for anthracycline antibiotic stimulation of oxygen consumption by HL-60 cells and mitochondria.
    Burke TG; Pritsos CA; Sartorelli AC; Tritton TR
    Cancer Biochem Biophys; 1987 Sep; 9(3):245-55. PubMed ID: 3124953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
    Jensen RA; Acton EM; Peters JH
    Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quercetin on daunorubicin-induced heart mitochondria changes in rats.
    Guzy J; Kusnír J; Mareková M; Chavková Z; Dubayová K; Mojzisová G; Mirossay L; Mojzis J
    Physiol Res; 2003; 52(6):773-80. PubMed ID: 14640900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by schisanhenol against adriamycin toxicity in rat heart mitochondria.
    Lin TJ; Liu GT; Pan Y; Liu Y; Xu GZ
    Biochem Pharmacol; 1991 Oct; 42(9):1805-10. PubMed ID: 1657000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines.
    Nohl H; Gille L; Staniek K
    Z Naturforsch C J Biosci; 1998; 53(3-4):279-85. PubMed ID: 9618942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.